Concepedia

Robert Yarchoan

RY

15

Publications

1.6K

Citations

14

H-Index

1986

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Cancer Research Center

Robert Yarchoan is an author at National Cancer Institute specializing in medicine, hiv, and pharmacology.

Top concepts

MedicineHivPharmacologyVirologyImmunologyNeurologyNeuroscienceNeurovirologyNeuropathologyPharmacotherapy

Publications per year

1986–1999

15

Publications

15

PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

Robert Yarchoan · The Lancet · 1988 · 510 citations

Medicine, Human Retrovirus, Immunology +7

CD4 Count and the Risk for Death in Patients Infected with HIV Receiving Antiretroviral Therapy

Robert Yarchoan, David Venzon, James M. Pluda et al. · Annals of Internal Medicine · 1991 · 158 citations

Ongoing HIV dissemination during HAART

Zvi Grossman, Michael A. Polis, Mark B. Feinberg et al. · Nature Medicine · 1999 · 147 citations

Sexual Health, Treatment And Prevention, Virology +5

Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′‐dideoxycytidine (ddc)

Richard Dubinsky, Robert Yarchoan, Marinos C. Dalakas et al. · Muscle & Nerve · 1989 · 113 citations

Neurobiology Of Disease, Neurovirology, Medicine +15

Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection [see comments]

Pluda Jm, Robert Yarchoan, Smith Pd et al. · Blood · 1990 · 98 citations · Full text

Rows per page

1–5 of 15